Next report date
Report period
Q1 2024
EPS estimate
0.56USD
Revenue estimate
1.07 BUSD
1.62USD
447.62 MUSD
2.65 BUSD
349.68 M
About NOVONESIS A S
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
Employees (FY)
6.76 K
ISIN
DK0060336014
FIGI
BBG000D840J2
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NVZMF is 52.51 USD — it has decreased by 3.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange NOVONESIS A S stocks are traded under the ticker NVZMF.
NOVONESIS A S is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
NVZMF stock is 3.69% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is NOVONESIS A S there?
NVZMF earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.41 USD resulting in a 16.84% surprise. The estimated earnings for the next quarter are 0.47 USD per share. See more details about NOVONESIS A S earnings.
NOVONESIS A S revenue for the last quarter amounts to 630.08 M USD despite the estimated figure of 623.16 M USD. In the next quarter revenue is expected to reach 683.72 M USD.
Yes, you can track NOVONESIS A S financials in yearly and quarterly reports right on TradingView.
NVZMF stock has fallen by 4.11% compared to the previous week, the month change is a 11.00% fall, over the last year NOVONESIS A S has showed a 0.30% decrease.
NVZMF net income for the last quarter is 103.32 M USD, while the quarter before that showed 132.35 M USD of net income which accounts for −21.93% change. Track more NOVONESIS A S financial stats to get the full picture.
Today NOVONESIS A S has the market capitalization of 25.82 B, it has increased by 0.83% over the last week.
NOVONESIS A S dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NVZMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS A S stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS A S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS A S technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS A S stock shows the sell signal. See more of NOVONESIS A S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVONESIS A S future price: according to them, NVZMF price has a max estimate of 67.74 USD and a min estimate of 49.91 USD. Read a more detailed NOVONESIS A S forecast: see what analysts think of NOVONESIS A S and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS A S EBITDA is 863.57 M USD, and current EBITDA margin is 32.72%. See more stats in NOVONESIS A S financial statements.